Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $802,998 - $1.17 Million
-17,306 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $451,354 - $588,750
9,172 Added 112.76%
17,306 $1.11 Million
Q3 2019

Nov 12, 2019

BUY
$42.77 - $50.71 $3,164 - $3,752
74 Added 0.92%
8,134 $412,000
Q2 2019

Aug 05, 2019

BUY
$44.62 - $49.34 $55,998 - $61,921
1,255 Added 18.44%
8,060 $366,000
Q1 2019

Apr 18, 2019

BUY
$45.12 - $53.8 $1,082 - $1,291
24 Added 0.35%
6,805 $325,000
Q4 2018

Jan 22, 2019

SELL
$48.76 - $63.23 $30,475 - $39,518
-625 Reduced 8.44%
6,781 $352,000
Q3 2018

Oct 25, 2018

SELL
$55.19 - $62.25 $21,744 - $24,526
-394 Reduced 5.05%
7,406 $460,000
Q2 2018

Jul 19, 2018

BUY
$50.53 - $62.98 $97,421 - $121,425
1,928 Added 32.83%
7,800 $432,000
Q1 2018

Apr 27, 2018

SELL
$59.92 - $68.98 $51,591 - $59,391
-861 Reduced 12.79%
5,872 $371,000
Q4 2017

Jan 31, 2018

BUY
$59.94 - $65.35 $31,408 - $34,243
524 Added 8.44%
6,733 $413,000
Q3 2017

Oct 19, 2017

BUY
$55.23 - $63.74 $8,174 - $9,433
148 Added 2.44%
6,209 $396,000
Q2 2017

Aug 10, 2017

SELL
N/A
-1,780 Reduced 22.7%
6,061 $338,000
Q2 2017

Aug 08, 2017

BUY
N/A
7,841
7,841 $426,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mycio Wealth Partners, LLC Portfolio

Follow Mycio Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mycio Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mycio Wealth Partners, LLC with notifications on news.